Editor's Note Moderna, Inc announced new clinical data on its “Omicron-containing bivalent” COVID-19 booster candidate and a vaccine candidate targeting the Omicron variant of concern, Healthcare Purchasing News (HPN) June 9 reports. The booster dose of the new mRNA vaccine reportedly had a “superior neutralizing antibody response…against the Omicron variant…